Table 2 General information of the six-year follow-up cohort
Variables | Baseline | 1-year follow-up | 2-year follow-up | 3-year follow-up | 4-year follow-up | 5-year follow-up | p* |
|---|---|---|---|---|---|---|---|
(N = 21,777) | (N = 19,330) | (N = 11,226) | (N = 8652) | (N = 7918) | (N = 4776) | ||
Age (years) | 43.98 ± 12.36 | 44.72 ± 12.36 | 45.57 ± 11.62 | 47.28 ± 11.86 | 48.47 ± 11.35 | 49.96 ± 11.31 | < 0.0001 |
Sex (male) | 14,250 (65.44%) | 12,504 (64.69%) | 7522 (67.00%) | 5432 (62.76%) | 4918 (62.11%) | 3086 (64.61%) | < 0.0001 |
Overweight or obesity | 8964 (41.16%) | 8312 (43.00%) | 5031 (44.82%) | 3732 (43.13%) | 3542 (44.73%) | 2174 (45.52%) | < 0.0001 |
Hypertension | 6267 (28.78%) | 7125 (36.86%) | 4781 (42.59%) | 4025 (46.52%) | 3864 (48.86%) | 2478 (51.88%) | < 0.0001 |
Dyslipidemia | 8168 (37.51%) | 8208 (42.46%) | 4880 (43.47%) | 3906 (45.15%) | 4301 (54.32%) | 2927 (61.29%) | < 0.0001 |
Hyperglycemia | 2297 (10.55%) | 2530 (13.09%) | 1780 (15.86%) | 1516 (17.52%) | 1555 (19.64%) | 1019 (21.34%) | < 0.0001 |
MS | 3289 (15.10%) | 3852 (19.93%) | 2632 (23.45%) | 2328 (26.90%) | 2361 (29.82%) | 1564 (32.75%) | < 0.0001 |